January 21, 2021
StreetInsider
N-of-One is an oncology diagnostics platform that enables clinical interpretation of molecular tests. Read more
N-of-One is an oncology diagnostics platform that enables clinical interpretation of molecular tests. Read more
CEO
Christine M. Cournoyer
OpGen is the top competitor of N-of-One. OpGen is headquartered in Gaithersburg, Maryland, and was founded in 2002. OpGen competes in the Biotechnology field. OpGen generates 66% the revenue of N-of-One.
January 21, 2021
Endpoints News
No recent acquisitions found related to N-of-One
Since N-of-One was founded in 2008, it has participated in 4 rounds of funding. In total N-of-One has raised $16.6M. N-of-One's last funding round was on Jan 2017 for a total of $7.0M
No recent investments found related to N-of-One